2009
DOI: 10.1111/j.1365-2818.2009.03153.x
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of acridine orange and SYTO 16 for in vivo imaging of the peritoneal tissues in mice

Abstract: SummaryThe effect of peritoneal injection of acridine orange and SYTO 16 in mice was investigated. Images of peritoneal tissues stained with these dyes and obtained through a confocal micro-endoscope are presented. Seventy-five Balb/c mice were split into five groups and given peritoneal injections of dye or saline. The proportions of negative outcomes in each group were compared using confidence intervals and the Fisher's exact statistical test. A statistically significant increase in adverse events due to dy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
15
0

Year Published

2010
2010
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(16 citation statements)
references
References 29 publications
1
15
0
Order By: Relevance
“…Mutagenicity, on the other hand, is a concern. We have recently completed a pilot study in our laboratory evaluating the safety of AO and SYTO 16 in a mouse model 41. The results showed no increase in death rate or cancer incidence in animals treated with a high doses of dye injected into the peritoneal cavity.…”
Section: Commentmentioning
confidence: 99%
“…Mutagenicity, on the other hand, is a concern. We have recently completed a pilot study in our laboratory evaluating the safety of AO and SYTO 16 in a mouse model 41. The results showed no increase in death rate or cancer incidence in animals treated with a high doses of dye injected into the peritoneal cavity.…”
Section: Commentmentioning
confidence: 99%
“…Recent work also demonstrated the feasibility of ex vivo mosaicing confocal microscopy to enable rapid detection of BCCs in skin excision specimens from MMS, using exogenous fluorescent contrast agents to stain nuclear morphology 7–9 . However, use of fluorescent contrast agents for in vivo imaging is still being tested for efficacy and toxicity 10,11 and this method is not yet ready for clinical use. Thus, reflectance‐based RCM imaging continues to advance more rapidly towards clinical applications 12–16 .…”
mentioning
confidence: 99%
“…In 2009, a group from USA also applied AO to some patients with ovarian disease in a clinical study of confocal laser laparoscopic biopsy under FDA approval [53]. The FDA in the USA has provided approval for the application of AO to particular clinical studies after investigation of the acute and chronic toxicity and carcinogenicity of AO using mice [54]. Our study using mice revealed that the LD 50 of AO following intravenous administration was 28-30 mg/kg [18].…”
Section: Toxicity and Carcinogeniety Of Aomentioning
confidence: 85%